Black Diamond Therapeutics to Present at the Jefferies Global Healthcare Conference
CAMBRIDGE, Mass. and NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
CAMBRIDGE, Mass. and NEW YORK, June 06, 2022 (GLOBE NEWSWIRE) — Black Diamond Therapeutics, Inc….
Jefferies Healthcare Conference European Hematology Association Congress, EHA-2022 BIO International Convention LSX World Congress MADRID,…
OREM, Utah, June 06, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
HALIFAX, Nova Scotia, June 06, 2022 (GLOBE NEWSWIRE) — Today, MedMira Inc. (MedMira) (TSXV: MIR)…
Aria Study did not achieve statistical significance on the primary endpoint Strategic realignment to focus…
Trial will evaluate AB-729, an RNAi therapy in combination with VTP-300, an immunotherapeutic, and NA…
PHILADELPHIA, June 06, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company…
PALO ALTO, Calif., June 06, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
Urges Stockholders to Vote “FOR” Radius’ Highly Qualified, Independent Director Nominees – Catherine J. Friedman,…
Cambridge, Mass. and Burnaby, British Columbia , June 06, 2022 (GLOBE NEWSWIRE) — Biogen and…
Study met its primary endpoint with 80.1% of individuals treated with roflumilast foam achieving Investigator…
YONKERS, N.Y., June 06, 2022 (GLOBE NEWSWIRE) — ContraFect Corporation (Nasdaq: CFRX), a late clinical-stage…
NEW YORK and CLEVELAND, June 06, 2022 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (Nasdaq: ABEO),…
Trial will evaluate AB-729, an RNAi therapy in combination with VTP-300, an immunotherapeutic, and NA…
AL01811 is a preclinical selective GBA2 inhibitor with first-in-class potential as an oral disease modifying…
RESEARCH TRIANGLE PARK, N.C., June 06, 2022 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today…
PRESS RELEASE Immunocore presents new data on KIMMTRAK (tebentafusp-tebn) in metastatic cutaneous (mCM) and uveal…
100% of dosed patients have exceeded both median and expected progression free survival (PFS). Two…
CHATHAM, N.J., June 06, 2022 (GLOBE NEWSWIRE) — Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix…
CALGARY, Alberta, June 06, 2022 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…